Tracks survival of adults with unresectable liver cancer in routine care
Observes how long adults with inoperable liver cancer survive under usual treatment in Asia Pacific.
Plain-language title generated from the registry record
Registry title: The Overall Survival of Patients With Unresectable HCC in Real-life
Key facts
- Where
- Hong Kong, Hong KongSee the site
Where in Hong Kong
- Humanity & Health Medical Group LimitedHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Humanity & Health Medical Group Limited
- Trial code
- NCT03612726
- Record updated
- 24 March 2025
- Original description
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The pattern of HCC occurrence shows a significant geographical imbalance, with the highest incidence rates in East Asia (more than 50% of the cases occurring in China).Read full original descriptionShow less
The Overall Survival of Patients Diagnosed With Unresectable Hepatocellular Carcinoma Under Real-life Clinical Practice in Asia Pacific Region
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The pattern of HCC occurrence shows a significant geographical imbalance, with the highest incidence rates in East Asia (more than 50% of the cases occurring in China).
The aim of this study is to investigate the overall survival (OS) of patients diagnosed with unresectable hepatocellular carcinoma under real-world practice conditions in Asia Pacific region.
Inclusion: Patients with a diagnosis of unresectable hepatocellular carcinoma; Able to comprehend and provide written informed consent in accordance with institutional guidelines.
Exclusion: Patients not willing to participate and/or give their written informed consent.